Trump Moves to Fast-Track Psychedelic Drug Research
TL;DR
Trump plans to sign an executive order to accelerate research into psychedelic drugs such as LSD, Ecstasy, and psilocybin and to ease federal restrictions, targeting PTSD, depression and other mental health conditions, with $50 million earmarked for state-level ibogaine studies — a push Texas has already backed with a $50 million commitment.
- Trump Expected to Loosen Restrictions on Psychedelic Drugs The New York Times
- Trump plans to ease access to psychedelics like psilocybin, ibogaine The Washington Post
- Trump to sign executive order on psychedelic drug used abroad to treat PTSD CBS News
- Trump set to ease restrictions on psychedelic drug used to treat PTSD Reuters
- Trump expected to sign executive order urging more research into psychedelic ibogaine CNN
Want the full story? Read the original reporting
Read on The New York Times